EX1
Exopharm Limited
🇦🇺 ASX
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual capital growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
1
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Exopharm Ltd. engages in the development and commercialization of exosomes as therapeutic agents. The company is headquartered in Melbourne, Victoria. The company went IPO on 2018-12-18. The firm's principal activities include pipeline products analysis and selection; technology development and validation; and commercial collaborations. The firm operates through regenerative medicine and biopharmaceutical drug development segment. Its exosome technologies solve the needs for the success of exosome medicines. Its technologies include LEAP manufacturing technology, LOAD active pharmaceutical ingredients (APIs) loading technologies, and EVPS tropism technologies. The firm is developing Engineered EVs (EEVs), an emerging form of precision medicine with application in areas, such as neurology, cardiology, and oncology. Its EEV technology includes EVPS to provide tissue tropism to exosomes and LOAD to load in APIs, such as messenger ribonucleic acid (mRNA).
📈 Performance
Price History
-94.35%
1M
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.01
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in EX1
1
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in EX1
1327 days
EX1 investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50%
50k - 100k
50%
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
100%
🙋 Legal gender of investors
Female
Male
100%
Pearlers who invest in EX1 also invest in...
BBUS.AX was created on 2015-08-24 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to help investors profit from, or protect against, a declining U.S. share market. It seeks to generate magnified returns that are negatively correlated to the returns of the U.S. share market (as measured by the S&P 500 index), hedged to Australian dollars.
📊 Share price
$8.85 AUD
Adairs Ltd. is engaged in retail operations in thef manchester and homewares. The company is headquartered in Melbourne, Victoria. The company went IPO on 2015-06-17. The firm owns and operates three vertically integrated brands in the home category: Adairs, Mocka and Focus on Furniture (Focus). Its Adairs is a retailer of home furnishings in Australia and New Zealand with a national footprint of stores across a number of formats and an online channel. The Company’s Mocka is a vertically integrated online home and living products designer and retailer operating in Australia and New Zealand. Its Mocka sells its products in the home furniture, decor, kids and baby categories. The Company’s Focus is a vertically integrated omnichannel furniture and bedding retailer offering products through its network of stores in Australia and its online channel.
📊 Share price
$1.94 AUD
Kogan.com Ltd. operates as an online retailer with a portfolio of retail and services businesses that includes Kogan Retail, Marketplace, Mobile, Broadband, Insurance and Travel. The company is headquartered in South Melbourne, Victoria. The company went IPO on 2016-07-07. The firm's businesses include Kogan Retail, Kogan Marketplace, Kogan Mobile, Kogan Internet, Kogan Insurance, Kogan Travel, Kogan Money, Kogan Cars, Kogan Energy, Dick Smith, Matt Blatt, Mighty Ape and Brosa. The firm's segments include Kogan.com and Mighty Ape. Kogan.com segment is an online retailer selling in-house and third-party brand household and consumer electronics products, as well as providing services for telecommunication, Internet, insurance, home finances, utilities, vehicles and travel. The Mighty Ape segment is an online specialist retailer of gaming and entertainment products. The firm's offering comprises products released under Kogan.com's brands, such as Kogan, Ovela, Fortis, Certa and Komodo (exclusive brands products), and products sourced from imported and domestic third-party brands, such as Apple, Canon, Swann and Samsung (third-party brands products).
📊 Share price
$4.61 AUD
Lovisa Holdings Ltd. engages in the retail sale of fashion jewelry and accessories. The company is headquartered in Hawthorn, Victoria. The company went IPO on 2014-12-18. The firm is primarily engaged in the retail sale of fashion jewelry and accessories. The firm is primarily focused on retailing fashion jewelry and accessories for women. The company is also focused on designing, developing, sourcing, and merchandising all its branded products. The firm's geographical segments include Australia and New Zealand, Asia, Africa, Americas and Europe and the Company's franchise stores in the Middle East and Asia. The company offers a range of accessories, including hair clips, watches, jewelry cases, anklets and gift cards. The firm utilizes its daily inventory monitoring software and airfreight to move product to store locations within 48 hours from its warehouses in Melbourne, China and Poland. The company operates approximately 629 retail stores in operation, including 44 franchise stores around the world.
📊 Share price
$21.33 AUD
ESGI.AX was created on 2018-03-06 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to provide investment returns before fees and other costs which track the performance of its Reference Index in Australian dollars.
📊 Share price
$29.97 AUD
NULL GLOBAL
NULL SMART BETA
NULL ETHICAL
NULL THEMATIC
Want more shares? Try these...
EX1N
Exopharm Ltd. engages in the development and commercialization of exosomes as therapeutic agents. The company is headquartered in Melbourne, Victoria. The company went IPO on 2018-12-18. The firm's principal activities include pipeline products analysis and selection; technology development and validation; and commercial collaborations. The firm operates through regenerative medicine and biopharmaceutical drug development segment. Its exosome technologies solve the needs for the success of exosome medicines. Its technologies include LEAP manufacturing technology, LOAD active pharmaceutical ingredients (APIs) loading technologies, and EVPS tropism technologies. The firm is developing Engineered EVs (EEVs), an emerging form of precision medicine with application in areas, such as neurology, cardiology, and oncology. Its EEV technology includes EVPS to provide tissue tropism to exosomes and LOAD to load in APIs, such as messenger ribonucleic acid (mRNA).